1.
Reich K, Goodfield M, Green L, Nograles K, Levi E, Langley RG. Safety and Efficacy of Apremilast Through 104 Weeks in Patients swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study. J of Skin [Internet]. 2017Oct.27 [cited 2022May17];1(3.1):s32. Available from: https://www.jofskin.org/index.php/skin/article/view/117